XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Financial instruments fair value (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The fair value of these financial instruments were as follows:
March 31, 2022
Level 1Level 2Level 3Total
(in thousands)
Cash equivalents:
Money market funds$126,048 $— $— $126,048 
Total cash equivalents$126,048 $— $— $126,048 
Contingent consideration:
Accrued liabilities$— $— $5,600 $5,600 
Total contingent consideration$— $— $5,600 $5,600 
December 31, 2021
Level 1Level 2Level 3Total
(in thousands)
Cash equivalents:
Money market funds$146,037 $— $— $146,037 
Total cash equivalents$146,037 $— $— $146,037 
Contingent consideration:
Accrued liabilities$— $— $4,588 $4,588 
Other liabilities— — 5,512 5,512 
Total contingent consideration$— $— $10,100 $10,100 
Schedule of Changes in Contingent Consideration
The following table provides a summary of the changes in contingent consideration, which is classified as Level 3:
Three Months Ended March 31,
20222021
(in thousands)
Balance, beginning of period$10,100 $8,200 
Additions— 359 
Total (gains) losses included in:
Net loss88 300 
Payments(4,588)— 
Other— (60)
Balance, end of period$5,600 $8,799 
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
The following table presents the net carrying value and estimated fair value of the 2026 Notes, which are not recorded at fair value in the condensed consolidated balance sheets:
March 31, 2022December 31, 2021
Net Carrying ValueEstimated Fair ValueNet Carrying ValueEstimated Fair Value
(in thousands)
2026 Notes
$362,648 $371,044 $362,031 $398,044